Back to search
Maturity-Onset Diabetes of the Young (MODY)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Maturity-Onset Diabetes of the Young (MODY) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Maturity-Onset Diabetes of the Young (MODY) trials you may qualify forThis observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile applicati…
This study aims to understand the heart and blood sugar health benefits of using an adjunctive therapy to lower high insulin levels in people with type 1 diabet…
The reason for this research study is to better understand the use of liraglutide, a commonly prescribed Type 2 diabetes medication, in patients with a diagnosi…
The goal of this 26 week randomized controlled clinical trial is to learn if using a real time continuous glucose monitor (CGM) in a healthy lifestyle program f…
The study has two aims: 1. To (1a) determine the frequency of monogenic diabetes misdiagnosed as type 1 diabetes (T1D) and (2) to define an algorithm for case…
The goal of this observation is to establish a complete registry for the clinical manifestations, environment, genetic, and other related gene variation informa…
Maturity-onset diabetes of youth (MODY) are the most frequent monogenic diabetes with autosomic dominant inheritance (2% of diabetes). The MODY2 diabetes is rel…
This randomized controlled trial will evaluate the effect of a nurse-led digital self-management education and support program on self-management behaviors, gly…